DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 129 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $272,971 | -20.0% | 21,460 | -11.4% | 0.17% | -17.8% |
Q2 2023 | $341,201 | +13.9% | 24,233 | +25.0% | 0.20% | +22.4% |
Q1 2023 | $299,622 | -4.0% | 19,393 | +1.8% | 0.16% | +1.2% |
Q4 2022 | $312,262 | -22.3% | 19,052 | -12.4% | 0.16% | +1.9% |
Q3 2022 | $402,000 | +42.6% | 21,744 | +1.5% | 0.16% | +52.4% |
Q2 2022 | $282,000 | -34.6% | 21,427 | +68.9% | 0.10% | -44.7% |
Q3 2021 | $431,000 | -15.0% | 12,686 | -8.4% | 0.19% | -8.7% |
Q2 2021 | $507,000 | +3.0% | 13,846 | +26.1% | 0.21% | 0.0% |
Q1 2021 | $492,000 | -19.3% | 10,979 | +2.8% | 0.21% | -17.8% |
Q4 2020 | $610,000 | +109.6% | 10,681 | +88.1% | 0.25% | +65.4% |
Q3 2020 | $291,000 | -24.6% | 5,678 | -12.1% | 0.15% | -16.4% |
Q2 2020 | $386,000 | +68.6% | 6,459 | +15.9% | 0.18% | +94.7% |
Q1 2020 | $229,000 | -42.3% | 5,572 | -12.5% | 0.09% | +44.6% |
Q4 2019 | $397,000 | -0.8% | 6,371 | -46.0% | 0.06% | -19.8% |
Q3 2019 | $400,000 | +42.3% | 11,793 | -5.3% | 0.08% | +37.3% |
Q2 2019 | $281,000 | +14.2% | 12,449 | +17.7% | 0.06% | -88.7% |
Q1 2019 | $246,000 | -0.4% | 10,578 | -10.2% | 0.52% | +1145.2% |
Q4 2018 | $247,000 | -44.1% | 11,773 | +3.1% | 0.04% | -8.7% |
Q3 2018 | $442,000 | -43.3% | 11,418 | -42.3% | 0.05% | -93.3% |
Q2 2018 | $779,000 | – | 19,795 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |